Notice of Intent to Publish a Funding Opportunity Announcement for NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed)
ID: 356830Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356830
Timeline
    Description

    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for the NINR Resources and Related Research Projects in Firearm Injury Prevention, designated as an R24 grant, which does not allow clinical trials. This initiative aims to support research projects focused on preventing firearm injuries, encouraging collaborations among researchers to develop impactful proposals. With an estimated total program funding of $2 million and an award ceiling of $500,000, the anticipated synopsis will be posted on November 29, 2024, with applications closing on January 28, 2025, and awards expected to be made by July 1, 2025. Interested applicants are encouraged to prepare their proposals in advance of these dates.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses," aimed at enhancing the training of nurse scientists and related fields in firearm injury prevention. This program seeks to develop and implement short courses (ranging from 2 to 12 weeks) that focus on evidence-based interventions, health equity, and the social determinants of firearm injuries, with an emphasis on addressing inequities across various demographics. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and government agencies, particularly those serving historically underrepresented groups, with funding available up to $200,000 per year for a maximum of three years. Applications are due by January 25, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Research on Community Level Interventions to Prevent Firearm and Related Violence, Injury and Mortality
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at supporting research on community-level interventions to prevent firearm and related violence, injury, and mortality. This initiative encourages applications that incorporate multiple intervention levels and sectors, such as health, education, and justice, and emphasizes collaboration with communities and organizations. The NIH seeks to adopt a comprehensive approach to understanding the causes of violence and suicide while promoting evidence-based prevention methods. Interested applicants should note that applications are not currently being solicited, but the FOAs are expected to be published in December 2022, with funding anticipated to begin in fiscal year 2022. For further inquiries, applicants can contact Dr. Dara R. Blachman-Demner at dara.blachman-demner@nih.gov or by phone at 301-496-8522.
    Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings," aimed at evaluating the effectiveness of interventions that promote the safe storage of potentially lethal means, such as firearms and medications, for individuals at increased risk of suicide. This initiative, through the National Institute of Mental Health (NIMH), seeks applications for R34 Planning Grants to conduct pilot effectiveness research on lethal means safety strategies, which have shown promise in reducing suicide attempts but require further evidence in healthcare and community settings. The total funding available is $1.5 million, with up to six grants awarded, each with a maximum budget of $450,000 over three years. Interested applicants must submit their proposals by June 15, 2024, for an initial review in November 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Research Grants to Rigorously Evaluate Innovative and Promising Strategies to Prevent Firearm-Related Violence and Injuries
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at rigorously evaluating innovative strategies to prevent firearm-related violence and injuries. This funding opportunity seeks investigator-initiated research that addresses various forms of firearm-related incidents, including mass shootings, homicides, suicides, and unintentional injuries, with the goal of enhancing the evidence base for effective prevention strategies. The total estimated program funding is $12.9 million, with an award ceiling of $650,000 and an expected ten awards to be made. Interested applicants must submit their proposals electronically by December 2, 2024, and can direct inquiries to Mikel Walters at ncipcerpo@cdc.gov.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science, inviting R01 research applications that focus on biomedical and behavioral research to inform tobacco product regulation. This initiative aims to generate scientific data that will enhance public health protections related to tobacco use, with a particular emphasis on fostering diverse perspectives through a simplified peer review framework. The total estimated funding for this program is $4 million, with an award ceiling of $500,000 for each of the anticipated five awards, and the NOFO is expected to be published in Winter 2024, with applications due in Summer 2025. Interested applicants should prepare to submit new applications, as only new proposals will be considered, and further details will be available upon the official release of the NOFO.
    Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Research Opportunities in Crisis Response Services for Suicide Prevention," aimed at supporting exploratory research into the effectiveness and implementation of crisis response services designed to prevent suicides. This initiative seeks to evaluate the impact of state and local policies on crisis service outcomes, focusing on real-world applications that consider various factors such as clinical presentations, geographic settings, cultural considerations, and health disparities. The total funding available is $2 million across fiscal years 2025-2026, with individual project budgets capped at $225,000 per year for a maximum of three years. Interested applicants can find more information and submission guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is June 2, 2025.
    Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)" aimed at advancing research on crisis response services related to suicide prevention. This initiative seeks proposals that examine the impact of state and local policies on the implementation and outcomes of crisis response services, particularly in the context of the 988 rollout, while considering various demographic and psychosocial factors. The program emphasizes the importance of real-world research settings and encourages community collaborations to enhance the practical application of findings. Up to $2,000,000 is available for this initiative, with the intention of awarding approximately 3-5 grants annually over a potential project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application window opening on September 1, 2024, and the close date set for June 2, 2025.
    Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)" aimed at exploring the role of inflammasomes in the context of HIV infection and substance use disorders. This R21 exploratory grant encourages research into the mechanisms of inflammasome activation and their association with neurocognitive disorders in individuals affected by HIV and substance use, with a focus on identifying molecular markers and potential therapeutic innovations. The total funding available is up to $2 million over two years, with applications opening on February 13, 2024, and a submission deadline of March 13, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI Research Specialist (Clinician Scientist) Award (R50), which will not allow clinical trials. This grant aims to support clinician scientists involved in NCI-funded clinical trials research by fostering stable research career opportunities and encouraging leadership in the development and implementation of clinical trials. The award is particularly significant as it seeks to enhance participation in NCI clinical trials networks, ensuring a diverse representation of institutions in the application process. The Notice of Funding Opportunity (NOFO) is expected to be published in late summer 2024, with a single application due date of November 5, 2024, and an estimated award date of May 30, 2025. Interested applicants should prepare their submissions accordingly, as applications are limited to four per institution.